Grace Therapeutics, Inc. (GRCE)
Net Income Growth
-80.83%
TTM · Period ending:
GRCE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-80.83%period ending
Latest reported-80.83%period ending
GRCE TTM Net Income YoY % (-71.68% → -80.83%)
Year-over-year change
High-resolution chart · PNG
GRCE net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -80.8293% | |
| 25.2957% | |
| 59.8383% | |
| 32.7206% | |
| 23.3475% | |
| 29.8758% | |
| 66.9373% | |
| 73.3535% | |
| 71.7701% | |
| 68.8588% | |
| -150.618% | |
| -165.7048% | |
| -284.0658% | |
| -318.492% | |
| -20.9028% | |
| -15.6088% | |
| 52.115% | |
| 60.6864% | |
| -4,615.5785% | |
| -144.3237% | |
| -70.1985% | |
| -89.1296% | |
| 99.3376% | |
| 84.4286% | |
| 59.1929% | |
| 55.2389% | |
| -69.1827% | |
| -36.3584% | |
| -113.184% | |
| -138.8749% | |
| -163.5195% | |
| -265.3186% | |
| -148.0329% | |
| -68.4458% | |
| -29.4598% | |
| -27.5038% | |
| -40.1295% | |
| -635.6847% | |
| -84.1618% | |
| -230.4774% | |
| -265.0742% | |
| 87.2726% | |
| 53.0083% | |
| 86.3997% | |
| 86.1382% | |
| 7.9092% | |
| -4.303% | |
| -57.4823% | |
| -55.7856% | |
| -16.562% | |
| 1.6105% | |
| 0.1628% | |
| -11.8048% | |
| -62.1814% | |
| -115.4307% | |
| -139.3277% | |
| -172.3514% | |
| -125.8529% | |
| -93.2833% | |
| -88.198% | |
| -71.6842% |